Medwing is a Healthtech company based in Berlin, Germany. It has raised $78M in total funding. Latest round: Series C.
Medwing funding overview
Medwing is a Healthtech company based in Berlin, Germany. Medwing has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2023. The round record for Medwing runs through 2023; nothing later has been disclosed. Investors on record include Hambro Perks, SVB Capital, Quadrille Capital, Cathay Innovation, Northzone, Cherry Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Medwing has raised $78M in total disclosed funding across the rounds on record.
Who has invested in Medwing?
Hambro Perks, SVB Capital, Quadrille Capital, Cathay Innovation, Northzone, Cherry Ventures are named among the investors backing Medwing.
What was the latest Medwing funding round?
The most recent disclosed round is a Series C, announced in March 2023.
Where is Medwing based?
Medwing is based in Berlin, Germany.
What sector does Medwing operate in?
Medwing is tracked under Healthtech from Berlin, Germany, with $78M in disclosed funding.
When did Medwing last raise?
The last disclosed Medwing round closed in March 2023 at Series C.
Every Medwing figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Healthtech companies in Berlin at a similar stage.
